Accepted Articles                   Back to the articles list | Back to browse issues page

XML Print

1- Department of Psychology, Islamic Azad University, Tehran Central Branch, Tehran, Iran.
Background: The COVID-19 pandemic has increased psychological distress and impacted diagnosis and treatment of noncommunicable diseases. This study aimed to examine the comparative effectiveness of Emotionally Focused Therapy (EFT) and Transcranial Direct Current Stimulation (tDCS) on anxiety and quality of life in patients with coronary artery disease (CAD) during COVID-19 pandemic.  
Methods: A total of forty-five participants who met criteria for a current episode of CAD, referred to Shahid-Rajaee Heart Hospital in Tehran, were chosen by convenience sampling method and they were randomly assigned to a 9-week/60-min EFT (n = 15) group therapy, 5-week/20-min tDCS (n = 15) experimental group and one control group (n=15). They were assessed at pre-treatment, post-group, and 3-month follow-up. The study subjects completed the self-reported reliable and valid Persian version of questionnaires, Beck Anxiety Inventory (BAI) and Health-Related Quality of Life (HRQOL). Then, repeated measures analysis of variance, ANOVA, was used to measure inferential statistics.
Results: There were significant improvements in Anxiety and Quality of Life scores in both EFT and tDCS groups over the post and follow-up period (p≤0.01). However, difference was found when EFT had a greater effect on Anxiety and Quality of Life.
Conclusions: These results showed EFT and tDCS have effective interventions in reducing anxiety and improving the quality of life of CAD patients, but improvements with EFT were greater than those with tDCS.
Type of Study: Original | Subject: Cognitive Neuroscience
Received: 2022/11/18 | Accepted: 2023/11/19

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb